Sensorion, a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, Sensorion announces the availability of its 1st Half 2023 Financial Report to the public and filed with the Autorité des marchés financiers.
September 26, 2023
· 3 min read